Skip to main content
SpringerLink
Log in

TAVI-Implantationen in Deutschland

Was rechtfertigt die aktuelle Studienlage?

TAVI in Germany

What have we learned from current studies?

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Die kathetergestützte Aortenklappenimplantation (TAVI) hat sich zur Therapie symptomatischer Aortenklappenstenosen bei inoperablen Patienten und solchen mit hohem Risiko etabliert. Das Verfahren hat inzwischen in Deutschland den chirurgischen Aortenklappenersatz als häufigstes Therapieverfahren überholt und entwickelt sich in Richtung der Behandlung von Patienten mit intermediärem Risiko. Bevor die TAVI aber auch bei Patienten mit niedrigerem operativen Risiko eingesetzt wird, sind Studien zu fordern, die die Sicherheit und die Effektivität dieser Methode für dieses Patientenkollektiv demonstrieren.

Abstract

Transcatheter aortic valve implantation (TAVI) has become an established treatment for symptomatic aortic valve stenosis in inoperable patients and high-risk patients. In Germany the TAVI procedure has now surpassed the annual numbers of isolated surgical aortic valve replacement with a recent trend towards treatment of intermediate-risk patients; however, before TAVI can also be used in patients with lower surgical risk, studies are required to demonstrate the safety and efficacy of this method for this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cribier A, Eltchaninoff H, Bash A, Borenstein N et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008

    Article  PubMed  Google Scholar 

  2. Holzhey D, Mohr FW, Walther T, Möllmann H et al (2015) Current results of surgical aortic valve replacement: insights from the German Aortic Valve Registry. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.07.090. (pii: S0003-4975(15)01350-8)

  3. Mack MJ, Leon MB, Smith CR, Miller DC et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484

    Article  PubMed  Google Scholar 

  4. Rearden M, Adams DH, Kleiman NS, Yakubov SJ et al (2015) 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66(2):113–121

    Article  Google Scholar 

  5. Walther T, Hamm CW, Schuler G et al (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements – prospective data from the GARY registry. J Am Coll Cardiol 65(20):2173–2180

    Article  PubMed  Google Scholar 

  6. Eggebrecht H, Mehta RH (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11(5). doi:10.4244/EIJY15M09

  7. Nishimura RA, Otto CM, Bonow RO, Carabello BA et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488

    Article  PubMed  Google Scholar 

  8. Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33(19):2451–2496

    Article  PubMed  Google Scholar 

  9. Holzhey D, Mohr FW, Walther T, Möllmann H et al (2015) Current results of surgical aortic valve replacement: insights from the German Aortic Valve Registry. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.07.090. (pii: S0003-4975(15)01350-8)

  10. Beckmann A, Funkat AK, Lewandowski J, Frie M et al (2015) Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 63:258–269

    Article  PubMed  Google Scholar 

  11. Kuck KH, Eggebrecht H, Figulla HR, Haude M et al (2015) Positionspapier zu Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI). Kardiologe 9:11–26

    Article  Google Scholar 

  12. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798

    Article  CAS  PubMed  Google Scholar 

  13. Facchin M, Mojoli M, Covolo E, Tarantini G (2014) The SAPIEN 3 valve: lights and shadows. Minerva Med 105(6):497–500

    CAS  PubMed  Google Scholar 

  14. Abdel-Wahab M, El-Mawardy M, Richardt G (2015) Update on transcatheter aortic valve replacement. Trends Cardiovasc Med 25:154–161

    Article  PubMed  Google Scholar 

  15. Généreux P, Head SJ, Hahn R, Daneault B et al (2013) Paravalvular leak after transcatheter aortic valve replacement: the new achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol 61:1125–1136

    Article  PubMed  Google Scholar 

  16. Kodali S, Pibarot P, Douglas PS, Williams M et al (2015) Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36:449–456

    Article  PubMed  Google Scholar 

  17. van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens L et al (2012) New conduction abnormalities after TAVI – frequency and causes. Nat Rev Cardiol 9:454–463

    Article  PubMed  Google Scholar 

  18. Hamm CW, Möllmann H, Holzhey D, Beckmann A et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598

    Article  PubMed  PubMed Central  Google Scholar 

  19. Webb JG (2014) 30-day outcomes from the SAPIEN 3 trial. http://www.pcronline.com/Lectures/2014/30-day-outcomes-from-the-SAPIEN-3-trial

  20. Fanning JP, Walters DL, Platts DG, Eamonn E et al (2014) Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture? Circulation 129:504–515

    Article  PubMed  Google Scholar 

  21. Kahlert P, Knipp SC, Schlamann M, Thielmann M et al (2010) Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7):870–878

    Article  PubMed  Google Scholar 

  22. Ghanem A, Müller A, Nähle CP, Kocurek J (2010) Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 55(14):1427–1432

    Article  PubMed  Google Scholar 

  23. Astarci P, Glineur D, Kefer J, D’Hoore W et al (2011) Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg 40(2):475–479

    PubMed  Google Scholar 

  24. Nijenhuis VJ, Bennaghmouch N, van Kuijk JP, D Capodanno D (2015) Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI). Thromb Haemost 113:674–685

    Article  PubMed  Google Scholar 

  25. Iung B, Rodés-Cabau J (2014) The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. Eur Heart J 35:2942–2949

    Article  PubMed  Google Scholar 

  26. David TE, Armstrong S, Maganti M (2010) Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg 90:775–781

    Article  PubMed  Google Scholar 

  27. Johnston DR, Soltesz EG, Vakil N, Rajeswaran J et al (2015) Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg 99(4):1239–1247

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Herz- und Thoraxchirurgie, Herzzentrum, Universitätsklinik zu Köln, Kerpener Strasse 62, 50937, Köln, Deutschland

    N. Mader & Th. Wahlers

  2. Klinik III für Innere Medizin, Herzzentrum, Universität zu Köln, Kerpener Straße 62, 50937, Köln, Deutschland

    T. Rudolph & S. Baldus

Authors
  1. N. Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Rudolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Baldus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Th. Wahlers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Mader.

Ethics declarations

Interessenkonflikt

N. Mader, T. Rudolph, S. Baldus und Th. Wahlers geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mader, N., Rudolph, T., Baldus, S. et al. TAVI-Implantationen in Deutschland. Herz 41, 97–101 (2016). https://doi.org/10.1007/s00059-016-4406-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-016-4406-8

Schlüsselwörter

Keywords

Search

Navigation